Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis.
Saved in:
| Title: | Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis. |
|---|---|
| Authors: | Norsworthy KJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. kelly.norsworthy@fda.hhs.gov., Mulkey F; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Scott EC; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Ward AF; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Przepiorka D; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Charlab R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Dorff SE; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Deisseroth A; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Kazandjian D; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Sridhara R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Beaver JA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Farrell AT; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., de Claro RA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Pazdur R; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland. |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Aug 15; Vol. 26 (16), pp. 4280-4288. Date of Electronic Publication: 2020 May 11. |
| Publication Type: | Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Comment |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32393603 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Norsworthy+KJ%22">Norsworthy KJ</searchLink>; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. kelly.norsworthy@fda.hhs.gov.<br /><searchLink fieldCode="AU" term="%22Mulkey+F%22">Mulkey F</searchLink>; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.<br /><searchLink fieldCode="AU" term="%22Scott+EC%22">Scott EC</searchLink>; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.<br /><searchLink fieldCode="AU" term="%22Ward+AF%22">Ward AF</searchLink>; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.<br /><searchLink fieldCode="AU" term="%22Przepiorka+D%22">Przepiorka D</searchLink>; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.<br /><searchLink fieldCode="AU" term="%22Charlab+R%22">Charlab R</searchLink>; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.<br /><searchLink fieldCode="AU" term="%22Dorff+SE%22">Dorff SE</searchLink>; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.<br /><searchLink fieldCode="AU" term="%22Deisseroth+A%22">Deisseroth A</searchLink>; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.<br /><searchLink fieldCode="AU" term="%22Kazandjian+D%22">Kazandjian D</searchLink>; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.<br /><searchLink fieldCode="AU" term="%22Sridhara+R%22">Sridhara R</searchLink>; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.<br /><searchLink fieldCode="AU" term="%22Beaver+JA%22">Beaver JA</searchLink>; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.<br /><searchLink fieldCode="AU" term="%22Farrell+AT%22">Farrell AT</searchLink>; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.<br /><searchLink fieldCode="AU" term="%22de+Claro+RA%22">de Claro RA</searchLink>; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.<br /><searchLink fieldCode="AU" term="%22Pazdur+R%22">Pazdur R</searchLink>; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2020 Aug 15; Vol. 26 (16), pp. 4280-4288. <i>Date of Electronic Publication: </i>2020 May 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Comment – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32393603 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/1078-0432.CCR-20-0834 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 4280 Titles: – TitleFull: Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Norsworthy KJ – PersonEntity: Name: NameFull: Mulkey F – PersonEntity: Name: NameFull: Scott EC – PersonEntity: Name: NameFull: Ward AF – PersonEntity: Name: NameFull: Przepiorka D – PersonEntity: Name: NameFull: Charlab R – PersonEntity: Name: NameFull: Dorff SE – PersonEntity: Name: NameFull: Deisseroth A – PersonEntity: Name: NameFull: Kazandjian D – PersonEntity: Name: NameFull: Sridhara R – PersonEntity: Name: NameFull: Beaver JA – PersonEntity: Name: NameFull: Farrell AT – PersonEntity: Name: NameFull: de Claro RA – PersonEntity: Name: NameFull: Pazdur R IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 08 Text: 2020 Aug 15 Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1557-3265 Numbering: – Type: volume Value: 26 – Type: issue Value: 16 Titles: – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research Type: main |
| ResultId | 1 |
